Low Demand For Antibody Drugs Against COVID-19
Federal officials are disappointed to find that the monoclonal antibody drugs they've shipped across the country aren't being used rapidly. These drugs are designed to prevent people recently diagnosed...
View Article1st Known U.S. Case Of U.K. Coronavirus Variant Found In Colorado
Copyright 2021 NPR. To see more, visit LEILA FADEL, HOST: The first U.S. case of the COVID-19 variant has been reported in Colorado. Health officials there say they've isolated a case of the variant...
View ArticleWhy The COVID-19 Vaccine Distribution Has Gotten Off To A Slow Start
Copyright 2021 NPR. To see more, visit LEILA FADEL, HOST: The campaign to vaccinate Americans against COVID-19 is getting off to a slower start than officials had hoped - much slower. Here's a key...
View ArticleDoctors Encouraged By Antibody Treatments For COVID-19
Many doses of the monoclonal antibody drugs that treat mild to moderate COVID-19 are sitting unused around the country. There are logistical problems with providing these drugs and skepticism over...
View ArticleTracking Down Antibody Treatment Is A Challenge For COVID-19 Patients
Monoclonal antibody drugs are supposed to help people with mild to moderate COVID-19 avoid the hospital, but it can be a challenge to find out where the treatment is offered. NPR has heard from people...
View Article3 Questions And The Emerging Answers About COVID-19 Vaccine Protection
As the COVID-19 vaccine rolls out, three big questions loom. First, can someone who has been vaccinated still spread the disease? Second, will the vaccine remain effective as the virus itself evolves?...
View ArticleAfter A Year Battling COVID-19, Drug Treatments Get A Mixed Report Card
Drugs to treat COVID-19 are being fast-tracked for development, but the pace can't match the astonishing speed that gave birth to the vaccines. But one year into the pandemic, there has been strong...
View ArticleA Rocky Road On The Way To Herd Immunity For COVID-19
Scientists estimate that somewhere between 70% and 85% of people need to be immune from the coronavirus before the disease will wane through a process known as herd immunity. Both natural immunity and...
View ArticleCOVID-19 Vaccines Could Add Fuel To Evolution Of Coronavirus Mutations
Mutations in the new coronavirus could reduce the effectiveness of vaccines against it. But vaccines themselves can also drive viral mutations, depending on exactly how the shots are deployed and how...
View ArticleHow Herd Immunity Works — And What Stands In Its Way
Loading... What will it take to finally halt the spread of the coronavirus in the U.S.? To answer that question we've created a simulation of a mock disease we're calling SIMVID-19. When you click "Run...
View ArticleLong-Term Studies Of COVID-19 Vaccines Hurt By Placebo Recipients Getting...
Tens of thousands of people who volunteered to be in studies of the Pfizer-BioNTech and Moderna COVID-19 vaccines are still participating in follow-up research. But some key questions won't be easily...
View ArticleVitamin C Apparently Not Useful For Sepsis After All
Copyright 2021 NPR. To see more, visit MARY LOUISE KELLY, HOST: The nation's attention has understandably been on COVID-19 over this past year. But in that same span of time, nearly as many people in...
View ArticleVitamin C Fails Again As Treatment For Sepsis
Though attention has understandably been on COVID-19 over the last year, nearly as many people in the hospital have died with a different condition: sepsis. A study now casts doubt on a once-promising...
View ArticleCould A Single-Dose Of COVID-19 Vaccine After Illness Stretch The Supply?
Public health officials say it's important to vaccinate as many people as quickly as possible to reduce the risk posed by new coronavirus variants. One strategy to stretch existing supplies – albeit...
View ArticleConvalescent Plasma Strikes Out As COVID-19 Treatment
More than half a million Americans have received an experimental treatment for COVID-19 called convalescent plasma. But a year into the pandemic, it's not clear who, if anyone, benefits from it. That...
View ArticleAntibiotic Use Ran High In Early Days Of COVID-19, Despite Viral Cause
Doctors treating COVID-19 patients early in the pandemic often reached for antibiotics. But those drugs were not helpful in most cases, and overuse of antibiotics is a serious concern. Several research...
View ArticleWoman Gets New Windpipe In Groundbreaking Transplant Surgery
A medical team in New York City says it has performed the first complete surgical transplant of a windpipe. The trachea is basically a tube that transports air to and from the lungs, so you might think...
View ArticleDrugs Targeting Immune Response To COVID-19 Show Promise
Researchers are reporting some progress in their search for drugs that tamp down the overwhelming immune reaction that can kill a patient with COVID-19. These reactions are triggered by coronavirus...
View Article'Monoclonal Antibodies' Can Keep Coronavirus In Check, But Won't Stem...
Copyright 2021 NPR. To see more, visit AILSA CHANG, HOST: Government officials are trying to figure out how to make better use of drugs that can keep people with COVID-19 out of the hospital. That is...
View ArticleAntibody Drugs For COVID-19 Are A Cumbersome Tool Against Surges
Government officials are trying to figure out how to make better use of drugs that can keep people with COVID-19 out of the hospital. That's an urgent but daunting challenge in Michigan, where...
View Article
